Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Brainstorm Cell
(NQ:
BCLI
)
0.3368
-0.0052 (-1.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Brainstorm Cell
< Previous
1
2
3
4
5
6
7
Next >
BCLI Stock Earnings: Brainstorm Cell Misses EPS for Q2 2024
August 14, 2024
BCLI stock results show that Brainstorm Cell missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
May 24, 2024
Via
Benzinga
BCLI Stock Earnings: Brainstorm Cell Reported Results for Q1 2024
May 14, 2024
Brainstorm Cell just reported results for the first quarter of 2024.
Via
InvestorPlace
Brainstorm Cell: Q4 Earnings Insights
April 01, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 01, 2024
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news for Wednesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 09, 2024
Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning!
Via
InvestorPlace
Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket
April 09, 2024
Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.
Via
Benzinga
BCLI Stock Earnings: Brainstorm Cell Beats EPS for Q4 2023
April 01, 2024
BCLI stock results show that Brainstorm Cell beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
April 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 25, 2024
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 19, 2024
Via
Benzinga
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
February 13, 2024
BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 12, 2024
Via
Benzinga
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales
Via
Benzinga
BCLI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm - BCLI
January 02, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm – BCLI
January 01, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
BCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm
December 31, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
BRAINSTORM CELL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm
December 29, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
BCLI FINAL DEADLINE ALERT: ROSEN, THE FIRST FILING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Initiated by the Firm - BCLI
December 29, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Brainstorm Cell, SolarEdge, and Barclays and Encourages Investors to Contact the Firm
December 28, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
BCLI DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action Commenced by the Firm – BCLI
December 28, 2023
From
The Rosen Law Firm PA
Via
GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI)
December 28, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.